Agfa-gevaert Nv · EURONEXT:AGFB

Agfa-gevaert Nv — Q2 2019 Earnings Presentation

26 slides from Agfa-gevaert Nv's earnings presentation, Aug 28, 2019

  1. Slide 1: Q2 2019 Results

    Q2 2019 Results Agfa-Gevaert Group August 28, 2019

  2. Slide 2: Transformation process

    Transformation process  Alliance Lucky HuaGuang Graphics: expansion of common sales platform. Milestones  Process to sell part of Agfa HealthCare to be launched in the course of autumn. As announced in May, the part that is to be sold mainly comprises the Hospital IT and Integrated Care businesses

  3. Slide 3: Sales by division 1H 2019

    Agfa-Gevaert Group Sales by division 1H 2019 = 1,115 million Euro 19% 36% Offset Solutions  Radiology Solutions  22% HealthCare IT  Digital Print and Chemicals  23% 3

  4. Slide 4: Agfa-Gevaert Group key figures

    Agfa-Gevaert Group Q2 ’19 Q2 ’18 ∆% HY ’19 HY ’18 ∆% Key figures (excl. IFRS 16) (excl. IFRS 16, (excl.curr.) (excl. IFRS 16) (excl. IFRS 16, (excl.curr.) in million Euro restated) restated) Profit & Loss Sales 576 559 3.0% 1115 1108 0.6% (1.6%) (-0.8%) Gross Profit* 196 180 8.9% 370 358 3.5% as a %

  5. Slide 5: Agfa-Gevaert Group profit and loss

    Agfa-Gevaert Group Q2 ’19 Q2 ’18 ∆% HY ’19 HY ’18 ∆% Key figures (excl. IFRS 16) (excl. IFRS 16, (excl. IFRS 16) (excl. IFRS 16, in million Euro restated) restated) Profit & Loss Adjusted EBIT* 42 35 17.1% 61 60 2.2% as a % of sales Restructuring/non- -11 -9 -15 -13 recurring Operating result 31 27

  6. Slide 6: Main drivers behind key figures

    Agfa-Gevaert Group Main drivers behind  Continuing the positive evolution of the first three months of the year, the Agfa-Gevaert Group’s top line grew by 3.0% key figures (1.6% excluding currency effects) in the second quarter of 2019. All major growth engines - including the inkjet product range,

  7. Slide 7: Net financial debt

    Agfa-Gevaert Group Net financial debt 311* in million Euro 255 117 118 140 144 99 137 194 52 55 40 27 22 19 18 -18 -37 Q1'16 Q2'16 Q3'16 Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 * IFRS 16 impact of 117 million Euro 7

  8. Slide 8: Working capital

    Agfa-Gevaert Group Working capital in million Euro Q2 2018 Q4 2018 Q2 2019 in million Euro Inventories 516 498 529 DIOH (in days) 118 117 125 Trade Receivables, Contract Assets, 351 374 343 Contract liabilities DSO (in days) 56 56 54 Trade Payables (226) (219) (216) DPO (in days) 52 52 51 Trade Work

  9. Slide 9: Corporate Services

    Corporate Services Q2 ’19 Q2 ’18 ∆% HY ’19 HY ’18 ∆% Key figures (excl. IFRS 16) (excl. IFRS 16, (excl.curr.) (excl. IFRS 16) (excl. IFRS 16, (excl.curr.) in million Euro restated) restated) Profit & Loss Adjusted EBITDA* -3.6** -3.6 1.7% -8.4 -7.2 16.2% Adjusted EBIT* -3.6** -3.6 2.4% -8.5 -7.2 17.

  10. Slide 10: Offset Solutions

    | \ ‘ \ Offset Solutions '

  11. Slide 11: Offset Solutions sales by business segment

    Offset Solutions Sales 1H 2019 = 406 million Euro by business segment 13% Digital computer-to-plate  Analog computer-to-film  87% 11

  12. Slide 12: Offset Solutions key figures

    Offset Solutions Q2 ’19 Q2 ’18 ∆% HY ’19 HY ’18 ∆% Key figures (excl. IFRS 16) (excl. IFRS 16, (excl.curr.) (excl. IFRS 16) (excl. IFRS 16, (excl.curr.) in million Euro restated) restated) Profit & Loss Sales 207 212 -2.6% 406 427 -5.0% (-4.0%) (-6.8%) Gross Profit* 53 57 -7.9% 101 116 -13.3% as a %

  13. Slide 13: Offset Solutions main drivers

    Offset Solutions  The Offset Solutions division was able to limit the decline of Main drivers behind its top line to 2.6%, showing a clearly positive evolution compared to the first three months of the year. The offset key figures industry continues to be challenging. The strong market- driven decl

  14. Slide 14: Digital Print & Chemicals

    Digital Print & Chemicals

  15. Slide 15: Digital Print & Chemicals sales by business segment

    Digital Print & Chemicals Sales 1H 2019 = 208 million Euro by business segment 37% Inkjet  50% Electronic Print  Films and Foils  13% 15

  16. Slide 16: Digital Print & Chemicals key figures

    Digital Print & Chemicals Q2 ’19 Q2 ’18 ∆% HY ’19 HY ’18 ∆% Key figures (excl. IFRS 16) (excl. IFRS 16, (excl.curr.) (excl. IFRS 16) (excl. IFRS 16, (excl.curr.) in million Euro restated) restated) Profit & Loss Sales 108 99 9.2% 208 194 7.6% (7.2%) (5.3%) Gross Profit* 33 26 25.1% 61 52 17.8% as a

  17. Slide 17: Digital Print & Chemicals main drivers

    Digital Print & Chemicals Main drivers behind  Based on the good performances of several growth engines, the Digital Print & Chemicals division’s top line grew key figures strongly. The division’s inkjet business posted solid double- digit revenue growth, driven by the good performance of the high-

  18. Slide 18: Radiology Solutions

    Radiology Solutions

  19. Slide 19: Radiology Solutions sales by business segment

    Radiology Solutions Sales 1H 2019 = 251 million Euro by business segment 6% Hardcopy  36% CR/DR  58% Classic Radiology  19

  20. Slide 20: Radiology Solutions key figures

    Radiology Solutions Q2 ’19 Q2 ’18 ∆% HY ’19 HY ’18 ∆% Key figures (excl. IFRS 16) (excl. IFRS 16, (excl.curr.) (excl. IFRS 16) (excl. IFRS 16, (excl.curr.) in million Euro restated) restated) Profit & Loss Sales 135 130 3.8% 251 246 2.1% (2.9%) (2.3%) Gross Profit* 51 45 13.8% 94 85 10.4% as a % of

  21. Slide 21: Radiology Solutions main drivers

    Radiology Solutions Main drivers behind  The Radiology Solutions division’s revenue increased by 3.8% compared to the second quarter of 2018. Firstly, the key figures hardcopy business reported substantial revenue growth based on the positive effects of the reorganization of the distribution channe

  22. Slide 22: HealthCare IT

    HealthCare IT

  23. Slide 23: HealthCare IT sales by business segment

    HealthCare IT Sales by business 1H 2019 = 249 million Euro segment 40% HCIS  Imaging IT Solutions  60% 23

  24. Slide 24: HealthCare IT key figures

    HealthCare IT Q2 ’19 Q2 ’18 ∆% HY ’19 HY ’18 ∆% Key figures (excl. IFRS 16) (excl. IFRS 16, (excl.curr.) (excl. IFRS 16) (excl. IFRS 16, (excl.curr.) in million Euro restated) restated) Profit & Loss Sales 127 119 7.2% 249 241 3.3% (5.6%) (1.6%) Gross Profit* 59 51 15.0% 115 105 9.3% as a % of sales

  25. Slide 25: HealthCare IT main drivers

    HealthCare IT  Both the Imaging IT Solutions business and the HealthCare Main drivers behind Information Solutions business contributed to the HealthCare IT division’s substantial top line growth. The HealthCare Information key figures Solutions business recorded close to double-digit revenue growt

  26. Slide 26: Questions & Answers

    Questions & Answers AGFA &

Agfa-Gevaert Group — Q2 2019 Earnings Presentation on 6ix